Besides, increased DDR1 is known to be associated with the progression and poor prognosis of non-small cell lung carcinoma, hepatocellular carcinoma, bladder cancer, and oral squamous cell carcinoma, indicating an important role of DDR1 in in tumor progression [8–11]. Here, DDR1 is linked to urinary bladder carcinoma.